Healthcare AI Acquisition Corp., a blank check company focused on effecting a merger or similar business combination, has released its Form 10-Q report for the third quarter of 2023. The report provides insights into the company's financial performance and operational activities, highlighting key developments and future outlook.
Financial Highlights
- Net Income: $828,847 for the three months ended September 30, 2023, and $4,024,595 for the nine months ended September 30, 2023, primarily driven by interest income on investments held in the Trust Account and changes in fair value of warrant liability.
- Net Income: $492,290 for the three months ended September 30, 2022, and $9,676,940 for the nine months ended September 30, 2022, with significant contributions from interest income on investments and changes in fair value of warrant liability.
- Interest Income on Investments Held in the Trust Account: $163,452 for the three months ended September 30, 2023, and $4,660,324 for the nine months ended September 30, 2023.
- Interest Income on Investments Held in the Trust Account: $973,225 for the three months ended September 30, 2022, and $1,275,125 for the nine months ended September 30, 2022.
- Change in Fair Value of Warrant Liability: $952,918 for the three months ended September 30, 2023, and $350,499 for the nine months ended September 30, 2023.
- Change in Fair Value of Warrant Liability: $219,062 for the three months ended September 30, 2022, and $9,200,588 for the nine months ended September 30, 2022.
- Formation and Operating Costs: $287,523 for the three months ended September 30, 2023, and $986,228 for the nine months ended September 30, 2023.
- Formation and Operating Costs: $261,873 for the three months ended September 30, 2022, and $954,754 for the nine months ended September 30, 2022.
Business Highlights
- Company Overview: Healthcare AI Acquisition Corp is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. As of the report date, no business combination target has been selected.
- Initial Public Offering: The company completed its Initial Public Offering on December 14, 2021, raising gross proceeds of $200 million through the sale of 20 million units at $10 per unit. An additional $15.6 million was raised through the sale of over-allotment units.
- Trust Account Management: Following the IPO, $219.9 million was placed in a trust account, invested in U.S. government securities or money market funds. The funds are intended for use in a future business combination.
- Sponsor Handover: On June 8, 2023, a share purchase agreement facilitated the transfer of founder shares from the Former Sponsor to the New Sponsor, Atticus Ale, LLC. This included amendments to allow conversion of Class B shares to Class A shares.
- Redemption and Share Conversion: Following the Sponsor Handover, significant redemptions occurred, reducing the trust account balance. Additionally, Class B shares were converted to Class A shares, impacting shareholder structure.
- Business Combination Timeline: The company has until December 14, 2024, to complete a business combination. Extensions are possible on a month-to-month basis by depositing $50,000 into the trust account for each extension.
- Management Changes: A new management team under Mr. Zikang Wu was appointed following the Sponsor Handover, replacing officers and directors associated with the Former Sponsor.
- Operational Strategy: The company intends to use proceeds from the IPO and private placement warrants to consummate an initial business combination. The strategy includes potential use of forward purchase agreements or backstop agreements.
- Future Outlook: The company faces uncertainty regarding its ability to consummate a business combination by the termination date. If unsuccessful, mandatory liquidation and dissolution will occur.
SEC Filing: